Purchase Order 75N92E18P00255

<p>The National Human Genome Research Institute awarded a purchase order to Partek, Incorporated valued at $16,494.00 on August 23, 2019. Performance is located in Bethesda, Maryland. The order is for bioinformatics software solutions, specifically Partek's genomic analysis platforms designed to support advanced genomic research and data analysis. The purchase order is firm fixed-price with an ultimate completion date of September 30, 2020. No small business set-aside was applied.</p>

<p>The National Human Genome Research Institute awarded a purchase order to Partek, Incorporated for $9,330.00 on May 2, 2018, with completion targeted for June 1, 2019. No set-aside applies. Performance occurs in Bethesda, Maryland. The order procures bioinformatics software solutions, specifically genomic analysis and visualization tools for federal research. Pricing is firm fixed price.</p>

Partek, Inc. was awarded an $83,050 firm fixed price purchase order by the National Institutes of Health's National Human Genome Research Institute to deliver the Partek Genomics Suite. The five-year contract will provide the genomic analysis software to support NIH's efforts to advance genome research from August 2017 through August 2022. No subcontractors or set aside designations were identified. The award was issued under NIH's broader research programs focused on advancing the understanding...

This is a firm fixed-price purchase order awarded by the National Heart Lung and Blood Institute (NHGRI), part of the National Institutes of Health (NIH), to Partek, Incorporated to procure a Partek Flow Enterprise Edition software suite with RNA-Seq, Single Cell, and ATAC-Seq analysis toolkits. The $274,320 contract has a performance period ending on September 9, 2026. Partek is a for-profit bioinformatics software company providing genomic analysis tools to federal agencies, with Illumina,...

<p>The National Human Genome Research Institute awarded a purchase order to Chesapeake Mission Critical LLC valued at $13,871.00 on August 25, 2017, with a completion date of September 8, 2017. Work is performed in Bethesda, Maryland. The order is priced on a firm-fixed-price basis with no set-aside applied. Specific requirements are not detailed in the source material.</p>

<p>The National Human Genome Research Institute awarded a purchase order to Biodiscovery, Inc. for $16,031.25 on December 18, 2017. Work is performed in Bethesda, Maryland. The order is for firm fixed price, with no small business set-aside. Ultimate completion is scheduled for December 29, 2017.</p>

This is a fixed-price purchase order contract awarded by the National Institute of Child Health and Human Development (NICHD), part of the National Institutes of Health (NIH), to Partek, Incorporated, a for-profit bioinformatics software company. The $3,670 contract is for Partek's Genomics Suite software, which provides capabilities for genomic data analysis, visualization, and management to support comparative medicine research, transcriptome analysis, and other applications. The contract...

Partek, Inc. was awarded a $3,670 purchase order by the National Institutes of Health's National Institute of Child Health and Human Development to provide Partek Genomics Suite software. The firm fixed price contract has a period of performance from September 5, 2014 through September 4, 2015. The software will support the research of James Kennison at the National Institutes of Health. No additional context was provided regarding subcontractors or the agency's programs. The Department of...

<p>The National Human Genome Research Institute awarded a purchase order to Life Technologies Corporation valued at $18,816.00 on August 31, 2018, with ultimate completion on September 28, 2018. Place of performance is Bethesda, Maryland. The order is priced as firm fixed price with no set-aside used. The source does not specify the items or services procured.</p>

<p>The National Human Genome Research Institute awarded a purchase order to Eurofins Genomics LLC for $14,975.00 on December 13, 2016, with a firm fixed price for research studies. Place of performance is Bethesda, Maryland. The order was not set-aside and carries an ultimate completion date of January 11, 2021.</p>